TABLE 2

Effects of clofibric acid on 2-PPA-CoA formation, acyl glucuronidation, and covalent binding in vivo in rat livers

Rats were pretreated i.p. with clofibric acid (160 mg/kg/day) or vehicle (0.1 M sodium bicarbonate) for 7 days. On day 8, rats received an i.p. injection of (RS)-[1-14C]2-PPA (130 mg/kg in 0.9% saline, 0.5 ml/rat). Livers were collected 2 h after (RS)-[1-14C]2-PPA administration. Values are expressed as the mean ± S.D. (n = 3).

2 h After Administration of (RS)-[1-14C]2-PPA AUC(0-2 h) Ratio (Treated/Control)a
Control Clofibric Acid-Treated
2-PPA-CoA (nmol/g liver) 73.6 ± 13.0 171 ± 7b 2.9
2-PPA glucuronide (nmol/g liver) 589 ± 27 534 ± 57 0.79
Covalent binding (pmol/mg protein) 195 ± 16 243 ± 21b
  • a AUC(0-2 h) in clofibric acid treated and control animals (n = 2 for each time points) was calculated from Fig. 2.

  • b P < 0.05 versus control, using unpaired Student's t test.